Droxidopa Capsule
Product Images NDC 63304-112

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Droxidopa (NDC 63304-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-droxidopa-200mglabel (Spl Droxidopa 200mglabel)

Droxidopa Capsules 200 mg oral capsules, packaged by Sun Pharmaceutical Industries, Inc. The label states the container holds 90 capsules and features dosage instructions and storage conditions. The NDC is 63304-104-90, and the label indicates the product is Rx only.*

FDA Label Image

Spl-droxidopa-300mglabel (Spl Droxidopa 300mglabel)

Label for Droxidopa Capsules 300 mg, oral dosage form, containing 90 capsules. The label states the presence of FD&C Yellow No. 5 as a color additive. Manufactured by Sun Pharmaceutical Industries, Inc. Includes storage and usage information along with an NDC barcode on the side.*

FDA Label Image

Spl-droxidopa-capsules-figure1 (Spl Droxidopa Capsules Figure1)

A line graph titled "Mean Change in OHSA Item 1 Score by Week in Study 306B" showing mean change in dizziness over an 8-week double-blind treatment phase. Two groups are represented: Placebo with a dashed line and Droxidopa with a solid line. The vertical axis ranges from 0 to -3.5 in mean change, and a baseline mean change of 5.1 units is noted. Droxidopa shows a decrease in dizziness scores over time compared to placebo, with a statistically significant difference at week 1 (p<0.05). Error bars indicate variability at each time point.*

FDA Label Image

Spl-droxidopa-capsules-figure2 (Spl Droxidopa Capsules Figure2)

A bar graph showing the percent of subjects with improvements in OHSA Question 1 scores comparing placebo and droxidopa groups. The x-axis represents improvement scores from -8 to 8, with negative values indicating worse outcomes and positive values indicating better. The y-axis indicates the percent of subjects. Droxidopa is shown with filled bars and placebo with open bars.*

FDA Label Image

Spl-droxidopa-capsules-structure (Spl Droxidopa Capsules Structure)

Chemical structure of droxidopa (L-threo-3,4-dihydroxyphenylserine), showing its molecular arrangement with hydroxyl, amine, and carboxyl functional groups attached to its aromatic and aliphatic carbon atoms.*

FDA Label Image

Spl-droxidopa-label100mg (Spl Droxidopa Label100mg)

Label for Droxidopa Capsules 100 mg, oral dosage form, containing 90 capsules. The label includes manufacturer information for Sun Pharmaceutical Industries, Inc., usage instructions, storage conditions, and warnings. The product is Rx only and displays the NDC number 63304-086-90.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.